| HPV prevalence | HIV+ patients N = 133 n (%) | HIV− patients N = 198 n (%) | P-value | Odds Ratio | |
| HPV | 105 (78.95) | 128 (64.65) | 0.005 | 2.05 [1.23 - 3.41] | |
| HPV-HR | 96 (72.18) | 113 (57.07) | 0.005 | 1.95 [1.21 - 3.12] | |
| HPV-BR | 76 (57.14) | 68 (34.34) | <0.001 | 2.54 [1.62 - 4.00] | |
| IM-HPV | 91(68.42) | 74 (37.37) | <0.001 | 3.63 [2.27 - 5.78] | |
| HPV-HR genotypes | HPV16 | 27 (20.30) | 14 (7.07) |
|
|
| HPV18 | 11 (8.27) | 10 (5.05) |
|
| |
| HPV26 | 0 (0.00) | 0 (0.00) |
|
| |
| HPV31 | 11 (8.27) | 16 (8.08) |
|
| |
| HPV33 | 19 (14.29) | 10 (5.05) |
|
| |
| HPV35 | 8 (6.02) | 3 (1.52) |
|
| |
| HPV39 | 9 (6.77) | 2 (1.01) |
|
| |
| HPV45 | 5 (3.76) | 4 (2.02) |
|
| |
| HPV51 | 21 (15.79) | 4 (2.02) |
|
| |
| HPV52 | 12 (9.02) | 17 (8.59) |
|
| |
| HPV53 | 20 (15.04) | 8 (4.04) |
|
| |
| HPV56 | 62 (46.62) | 55 (27.78) |
|
| |
| HPV58 | 17 (12.78) | 14 (7.07) |
|
| |
| HPV59 | 2 (1.50) | 4 (2.02) |
|
| |
| HPV66 | 9 (6.77) | 24 (12.12) |
|
| |
| HPV68 | 15 (11.28) | 24 (12.12) |
|
| |
| HPV69 | 0 (0.00) | 7 (3.54) |
|
| |
| HPV73 | 13 (9.77) | 9 (4.55) |
|
| |
| HPV82 | 24 (18.05) | 14 (7.07) |
|
| |
| HPV-BR genotypes | HPV6 | 15 (11.28) | 9 (4.54) |
|
|
| HPV11 | 0 (0.00) | 1 (0.50) |
|
| |
| HPV40 | 4 (3.01) | 2 (1.01) |
|
| |
| HPV42 | 42 (31.58) | 28 (14.14) |
|
| |
| HPV43 | 21 (15.79) | 10 (5.05) |
|
| |
| HPV44 | 11 (8.27) | 10 (5.05) |
|
| |
| HPV54 | 15 (11.28) | 16 (8.08) |
|
| |
| HPV61 | 6 (4.51) | 5 (2.53) |
|
| |
| HPV70 | 13 (9.77) | 7 (3.54) |
|
| |